Fargesin - CAS 31008-19-2
Catalog number: 31008-19-2
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C21H22O6
Molecular Weight:
370.39
COA:
Inquire
Targets:
β1AR
Description:
Fargesin as a potential β1AR antagonist through cAMP/PKA pathway could protect against myocardial ischemia/reperfusion injury in rats. It also improves dyslipidemia and hyperglycemia by activating Akt and AMPK in WAT.
Publictions citing BOC Sciences Products
  • >> More
Purity:
>98%
Appearance:
Cryst.
Synonyms:
(1R)-4β-(1,3-Benzodioxole-5-yl)-3aβ,4,6,6aβ-tetrahydro-1α-(3,4-dimethoxyphenyl)-1H,3H-furo[3,4-c]furan; (1S,3aβ,6aβ)-1β-(1,3-Benzodioxole-5-yl)-4α-(3,4-dimethoxyphenyl)tetrahydro-1H,3H-furo[3,4-c]furan; (1β,5β)-2α-(3,4-Dimethoxyphenyl)-6β-(1,3-benzodioxole-5-yl)-3,7-dioxabicyclo[3.3.0]octane; 5-[(1β,3aβ,4α,6aβ)-4-(3,4-Dimethoxyphenyl)tetrahydro-1H,3H-furo[3,4-c]furan-1-yl]-1,3-benzodioxole; Methyl pluviatilol; 1,3-Benzodioxole,5-[(1R,3aS,4S,6aS)-4-(3,4-dimethoxyphenyl)tetrahydro-1H,3H-furo[3,4-c]furan-1-yl]-,rel-
MSDS:
Inquire
Application:
Anti-inflammatory/antihypertensive
Quality Standard:
Enterprise Standard
Quantity:
Milligrams-Grams
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Chemical Structure

CAS 31008-19-2 Fargesin

Quick Inquiry

Verification code

Featured Items